TY  - GEN
AU  - Kooijman,M
AU  - van Meer,P J K
AU  - Gispen-de Wied,C C
AU  - Moors,E H M
AU  - Hekkert,M P
AU  - Schellekens,H
TI  - The risk-based approach to ATMP development - generally accepted by regulators but infrequently used by companies
SN  - 1096-0295
PY  - 2014///0610
KW  - Animals
KW  - Drug Evaluation
KW  - methods
KW  - Drug Evaluation, Preclinical
KW  - Drug Industry
KW  - Government Agencies
KW  - Government Regulation
KW  - Netherlands
KW  - Risk Assessment
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.yrtph.2013.07.014
ER  -